Retinal layer thickness is decreased in glaucomatous eyes

Article

The thickness of several different layers of the retina is reduced in eyes with glaucoma

"With this in mind, our research team conducted a study focusing on the role of the macula in glaucoma, analysing the configuration of the retinal layers to isolate any pathologic thinning in glaucomatous eyes and to identify the topographic distribution of any such thinning," he said. The results of the study were presented at the most recent annual congress of the European Association for Vision and Eye Research (EVER), which was held in Nice, France.

For the purposes of this study, the team were specifically interested in the retinal nerve fibre layer (RNFL), the retinal ganglion cell plus inner plexiform layer (RGIPL) and the retina as a whole. The central 5° area of the macula was then also divided into 65 segments for further evaluation.

"The maculae of healthy subjects (n = 112; age range: 20–76 years) were scanned with the Cirrus (Carl Zeiss Meditec, Jena, Germany) high definition optical coherence tomography (HD-OCT) instrument, and the 512 x 128 three-dimensional scans were then subjected to quantitative analysis using Matlab R2009b software (The Mathworks Inc., Cambridge, UK), which was developed by our research team," Dr Holzer added. Matlab R2009b locates and 'locks on' to the fovea to increase the accuracy of the positioning of the HD-OCT, as focusing is difficult for glaucoma patients; once the eye is in the correct position, the software automatically detects retinal layers without any manual correction required, which is unique.

He continued, "Using the thickness data we gathered from these scans of healthy eyes, we built colour-coded thickness maps and a normative database (taking into account the effects of age), against which we compared thickness data gathered from subjects with glaucoma of varying stages (n = 25; age range: 42–79 years)." Patients with pre-existing retinal neuropathy were excluded from the study.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.